Columbia University

E-bike injuries surged 293% and powered scooter injuries rose 88% from 2019 to 2022, according to Columbia University researchers. The study highlights the need for improved safety measures and regulations to make micromobility a safer transportation option.

A study by Columbia University's Herbert Irving Comprehensive Cancer Center identified a drug combination, rosiglitazone plus trametinib, effective in treating muscle-invasive bladder cancer in mice, inducing tumor cell death and shifting aggressive cells to a more benign subtype, with plans to advance to clinical trials.

A study by Columbia University researchers found that combining Rosiglitazone and Trametinib significantly reduced muscle-invasive bladder cancer tumors in mice by 91%, shifting aggressive cells to a more benign subtype, with potential for clinical trials in humans.

Anna Lasorella, M.D., discusses her research on brain tumor vulnerabilities and the use of precision medicine to find cancer cures. As director of the Precision Medicine Initiative at Sylvester Comprehensive Cancer Center, she aims to establish a pipeline for reliable, patient-specific tumor models to tailor treatments based on molecular characteristics. Her current project studies the spatial architecture of tumors to understand their aggressiveness and resistance to immunotherapy.

Only 25% of U.S. adults with schizophrenia receive minimally adequate treatment, with 52% also having depression and 17% PTSD. Despite healthcare coverage, only 30% were on antipsychotic medication, highlighting the need for improved access to evidence-based interventions.

Haaretz.com, the online English edition of Haaretz Newspaper in Israel, provides breaking news, analyses, and opinions on Israel, the Middle East, and the Jewish World.

A study finds no higher autism risk in children born during the COVID-19 pandemic, even if exposed to COVID in the womb, reassuring parents and doctors about developmental health.

Oxford Drug Design's AI platform, SynthAI, validated in vivo with a 28-day mouse trial showing efficacy and dose response against MCF7 breast cancer cells. The platform's precision aims to deliver more efficacious and safer cancer treatments, accelerating development and reducing costs. The company plans to advance these treatments into clinical trials.

Justin Starren, MD, PhD, became a doctor to prevent medical tragedies like his father's death from steroid-induced pneumonia. He pivoted to biomedical informatics, aiming to impact more lives through technology and data. Now at the University of Arizona Health Sciences, he leads the Center for Biomedical Informatics and Biostatistics, focusing on health disparities and data ethics, particularly for Native American and Hispanic communities.

Focus on Lyme and Aces Diagnostics Inc. announced a breakthrough Lyme disease diagnostic test, LymeSeek™, with over 90% accuracy across all stages, including early detection. Developed with Tulane University, it aims to reduce misdiagnoses and chronic illness, targeting FDA clearance by 2026.